NEW YORK (GenomeWeb) – Cellular Dynamics will supply its iCell products for drug discovery to Roche and collaborate on identifying novel drug candidates, the company said today.

Under the terms of the agreement, Roche will have exclusive access to certain iCell products, derived from induced pluripotent stem cells (iPSCs), for use in high-throughput screening and lead optimization for drug discovery.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Even when given the option, not too many authors choose double-blinded peer-review for their manuscripts, ScienceInsider reports.

In PNAS this week: transcriptional read-through in stressed cells, genome stability role for the epigenetic regulator CTCF, and more.

The Save the Redwoods League is teaming with researchers to sequence the genomes of the coast redwood and giant sequoia.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.